Is it time to refine HCC surveillance strategies in HCV cured patients?
- PMID: 35218241
- DOI: 10.1002/hep.32430
Is it time to refine HCC surveillance strategies in HCV cured patients?
Comment on
-
HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis.Hepatology. 2022 Jul;76(1):139-154. doi: 10.1002/hep.32341. Epub 2022 Feb 7. Hepatology. 2022. PMID: 35030279 Free PMC article.
References
REFERENCES
-
- European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C: final update of the series. J Hepatol. 2020;73:1170-218.
-
- Ghany MG, Morgan TR; AASLD-IDSA Hepatitis C Guidance Panel. Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases-Infectious Disease Society of America recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology. 2020;71:686-721.
-
- Van der Meer AJ, Feld JJ, Hofer H, Almasio PL, Calvaruso V, Fernandez-Rodriguez CM, et al. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C eradication. J Hepatol. 2017;66:485-93.
-
- D’Ambrosio R, Degasperi E, Anolli MP, Fanetti I, Borghi M, Soffredini R, et al. Incidence of liver- and non-liver-related outcomes in patients with HCV-cirrhosis after SVR. J Hepatol. 2022;76:302-10.
-
- D’Ambrosio R, Degasperi E, Lampertico P. Predicting hepatocellular carcinoma risk in patients with chronic HCV infection and a sustained virological response to direct-acting antivirals. J Hepatocell Carcinoma. 2021;8:713-39.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources